Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP...
-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(17)
•••
Stockmoneyman17
X
View Profile
View Bullboard History
Post by
Stockmoneyman17
on Jan 22, 2021 9:28am
Just The Begging!
https://apple.news/AobuJO6QVQq-gLSuSdpf_FQ This is just the start for HEM! Great News IMO...GLTA
(95)
•••
Walterthedog
X
View Profile
View Bullboard History
Post by
Walterthedog
on Jan 20, 2021 10:04am
Caladrius
Its funny, i was just looking at comparables and found caladrius last week. Two phase 2 trials ongoing and licensing in Korea and a 30M$ MC? Anyways today theyre up 150% because of a buy rating. Go
...more
Discover Options Trading Strategies to Minimize your Tax Burden
posted Nov 30, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(79)
•••
Pimpovish
X
View Profile
View Bullboard History
Comment by
Pimpovish
on Jan 19, 2021 1:29pm
RE:RE:$29 million vs $525 million
You created a profile today to post this info? This is still a speculative stock and with it comes a compelling risk reward opportunity. Hemostemix's bio tech is not limited to CLI. It covers the
...more
(12)
•••
Cautus99
X
View Profile
View Bullboard History
Comment by
Cautus99
on Jan 19, 2021 11:22am
RE:RE:$29 million vs $525 million
well said bryguy.
(3)
•••
BryGuy73
X
View Profile
View Bullboard History
Comment by
BryGuy73
on Jan 19, 2021 10:38am
RE:$29 million vs $525 million
First off, while I agree that HEM is undervalued and has huge potential, but it is not really a fair comparison with SVA. 1. There's WAY more money in diabetes. More patients
...more
(18)
•••
Habland
X
View Profile
View Bullboard History
Post by
Habland
on Jan 19, 2021 10:02am
Phase 3 ?
This company will not need a phase 3 , so they are that much closer to licensing . Have a great day
(44)
•••
Dudeforever
X
View Profile
View Bullboard History
Comment by
Dudeforever
on Jan 18, 2021 9:44pm
RE:$29 million vs $525 million
In case anyone is interested, a $525 million market cap would bring us to a share price of $9.41. These predictions of $5-7 are not far-fetched.
(79)
•••
Pimpovish
X
View Profile
View Bullboard History
Post by
Pimpovish
on Jan 18, 2021 9:36pm
$29 million vs $525 million
HEM closed today with a marketcap of $29 million. SVA closed at a marketcap of $525 million. Wtf. HEM has 91 patents, 10 years of data around an enrolment of 500 patients and is in Phase 2 (Orphan
...more
(111)
•••
Ravens1
X
View Profile
View Bullboard History
Comment by
Ravens1
on Jan 18, 2021 8:15pm
RE:Peer comp SVA—now $450 million marketcap
what is the next catalyst you looking for to get a 10x ?
(79)
•••
Pimpovish
X
View Profile
View Bullboard History
Post by
Pimpovish
on Jan 18, 2021 3:37pm
Peer comp SVA—now $450 million marketcap
HEM @ $26 million--wtf Great trial results and a stock runs. This is a 10x move in less than 2 months! Shows how HEM can run on great midpoint numbers. V:SVA - Sernova Corp
...more
(95)
•••
Walterthedog
X
View Profile
View Bullboard History
Post by
Walterthedog
on Jan 15, 2021 11:14pm
Dudeforever
Haha. You pretty well nailed it there dude. Of course we dont know what those numbers are but either someone at HEM has a good idea or they are really confident or they are full of sh1t and needed to
...more
(44)
•••
Dudeforever
X
View Profile
View Bullboard History
Comment by
Dudeforever
on Jan 15, 2021 9:38pm
RE:Wtf and wtf—amazing upside based on peer company review
I think it's a reasonable assumption that the share price will hit $5 to $7 this year but...the company has to deliver honest to goodness great mid-point results. If they don't, the
...more
(79)
•••
Pimpovish
X
View Profile
View Bullboard History
Post by
Pimpovish
on Jan 15, 2021 6:07pm
Wtf and wtf—amazing upside based on peer company review
V.SVA now has a marketcap of $267 million. it's up 400% in a month and a half. HEM has a marketcap of $26 million. Have a look fellow investors. As far as I am concerned HEM appears far more
...more
(17)
•••
Ventrue
X
View Profile
View Bullboard History
Comment by
Ventrue
on Jan 14, 2021 7:43pm
RE:RE:Hemostemix stock really undervalued but...
What are u talking about? There was a >100,000 share bid at 45 today. Seems like price support to me Not trying to sound snarky, just sayin'
(95)
•••
Walterthedog
X
View Profile
View Bullboard History
Comment by
Walterthedog
on Jan 14, 2021 10:55am
RE:Hemostemix stock really undervalued but...
It seems to me like a simple thing for management to give us an updated time frame on midpoint results considering how our original time-frame is by tomorrow. Maybe Thomas was giving us an optimistic
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >